Skip to main content
Contact Us
Subscribe
E-Edition
37°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
US Healthcare Ishares ETF
(NY:
IYH
)
60.65
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2
Open
60.65
Bid (Size)
59.85 (2)
Ask (Size)
61.74 (2)
Prev. Close
60.65
Today's Range
60.65 - 60.65
52wk Range
54.09 - 66.59
Shares Outstanding
531,000
Dividend Yield
1.54%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
November 13, 2024
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.
Via
Benzinga
Topics
Government
Exposures
Political
Product Safety
What Lies In Store For Healthcare ETFs In Q3 Earnings?
October 27, 2024
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.
Via
Talk Markets
Topics
ETFs
Performance
YTD
+4.30%
+4.30%
1 Month
-5.01%
-5.01%
3 Month
-7.22%
-7.22%
6 Month
-0.25%
-0.25%
1 Year
+11.22%
+11.22%
More News
Read More
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
October 10, 2024
Via
Benzinga
Defensive ETFs Shine Amid A Rough Start To September
September 04, 2024
Via
Talk Markets
Topics
ETFs
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
Via
Benzinga
Delta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'
July 23, 2024
Via
Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
July 17, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
June 22, 2024
Via
The Motley Fool
'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
May 13, 2024
Via
Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Via
Talk Markets
Topics
ETFs
Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
March 11, 2024
Via
Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Via
Benzinga
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
December 13, 2023
Via
Benzinga
Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
December 10, 2023
Via
Benzinga
Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
December 04, 2023
Via
Benzinga
Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
November 24, 2023
Via
Benzinga
Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
October 05, 2023
Via
Benzinga
Exposures
Product Safety
All eyes on the Fed as inflation metrics give mixed signals
September 19, 2023
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
August 17, 2023
Via
Benzinga
4 Top-Ranked Sector ETFs To Buy In The Second Half
July 12, 2023
Via
Talk Markets
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
Via
Benzinga
The 3 Most Promising Industries to Invest in for 2023’s Second Half
June 27, 2023
Via
InvestorPlace
Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
March 17, 2023
Via
Talk Markets
Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
February 15, 2023
Via
The Motley Fool
Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
January 17, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.